Paper38623
The long-term hypotensive effect of timolol maleate compared with the effect of pilocarpine in simple and capsular glaucoma.
Airaksinen PJ. Acta Ophthalmol (Copenh), 1979. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. The long-term hypotensive effect of timolol maleate compared with the effect of pilocarpine in simple and capsular glaucoma. Papers, record 38623. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38623
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The long-term hypotensive effect of timolol maleate compared with the effect of pilocarpine in simple and capsular glaucoma.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glaucoma | Major topic |
| Pilocarpine | Major topic |
| Propanolamines | Major topic |
| Timolol | Major topic |
| Adrenergic beta-Antagonists | |
| Adult | |
| Aged | |
| Drug Evaluation | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Intraocular Pressure | |
| Male | |
| Middle Aged | |
| Miotics | |
| Ophthalmic Solutions | |
| Time Factors |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37314597 | RNA-seq analysis of human trabecular endothelial cells after treatment with timolol maleate. | Jpn J Ophthalmol | 2023 | https://conductscience.org/library/papers/37314597 | PubMed |
| 30794789 | Effect of Timolol on Aqueous Humor Outflow Facility in Healthy Human Eyes. | Am J Ophthalmol | 2019 | https://conductscience.org/library/papers/30794789 | PubMed |
| 29965903 | Recent Advances in the Surgical Management of Glaucoma in Exfoliation Syndrome. | J Glaucoma | 2018 | https://conductscience.org/library/papers/29965903 | PubMed |
| 10365038 | Course of exfoliation and simplex glaucoma after primary trabeculectomy. | Br J Ophthalmol | 1999 | https://conductscience.org/library/papers/10365038 | PubMed |
| 7141232 | Timolol treatment of chronic open-angle glaucoma and ocular hypertension. A 2.5-year multicenter study. | Graefes Arch Clin Exp Ophthalmol | 1982 | https://conductscience.org/library/papers/7141232 | PubMed |
| 7075965 | The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland. | Graefes Arch Clin Exp Ophthalmol | 1982 | https://conductscience.org/library/papers/7075965 | PubMed |
| 1351412 | Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects. | Drugs Aging | 1992 | https://conductscience.org/library/papers/1351412 | PubMed |
| 526463 | Management of acute closed-angle glaucoma with miotics and timolol. | Br J Ophthalmol | 1979 | https://conductscience.org/library/papers/526463 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38623
GET https://conductscience.org/api/papers/v1/38623/authors